Adalimumab (ADA) has been widely used in the treatment of psoriasis. In this retrospective single-center study, we evaluate effectiveness and safety ADA provide information on prevalence comorbidities patients with psoriasis real-world settings. 13,203 were collected. Moreover, 161 treated included for further analysis. Paired t-test was to changes HDL-C, LDL-C, TG, TC, ALT, AST, glucose, uric ...